AVIR
Atea Pharmaceuticals Inc.
Company Overview
| Mkt Cap | $254.74M | Price | $3.25 |
| Volume | 660.48K | Change | -0.61% |
| P/E Ratio | -1.5 | Open | $3.27 |
| Revenue | -- | Prev Close | $3.27 |
| Net Income | $-168.4M | 52W Range | $2.46 - $4.02 |
| Div Yield | N/A | Target | $6.00 |
| Overall | 75 | Value | 60 |
| Quality | -- | Technical | 90 |
No chart data available
Stock Overview
Updated DailyAtea Pharmaceuticals Inc. (AVIR) is a leading Manufacturing company in the Pharmaceutical Preparation Manufacturing industry, currently trading at $3.25 with a market capitalization of $254.74 million. The stock is trading in the middle of its 52-week range, demonstrating unrated quality characteristics with a MarketXLS quality score of N/A.
Today's trading session shows AVIR with a volume of 660K shares. The stock opened down 0.00% from yesterday's close of $3.27. Current analyst estimates project earnings of $-1.79 per share for this year, with next year targeting $-1.79.
AVIR demonstrates very strong technical momentum based on technical analysis. The company trades on the NGS exchange and operates alongside industry peers including OTIC, OTLC, OVAT-CA, ORTH-CA.
Key investment considerations for AVIR include strong overall investment metrics. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 84.6%. The stock shows fair valuation metrics based on valuation analysis.
Analysis generated on November 2, 2025 at 03:06 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | AVIR | $3.25 | -0.6% | 660.48K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Atea Pharmaceuticals Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW